Shandong Sinobioway Biomedicine Co., Ltd. (SHE:002581)

China flag China · Delayed Price · Currency is CNY
3.300
-0.160 (-4.62%)
Jul 30, 2026, 3:04 PM CST
Market Cap2.18B -55.0%
Revenue (ttm)283.34M -9.2%
Net Income-133.66M
EPS-0.20
Shares Out 659.74M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,233,408
Open3.290
Previous Close3.460
Day's Range3.290 - 3.480
52-Week Range3.040 - 9.250
Beta0.02
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHE:002581

Shandong Sinobioway Biomedicine Co., Ltd. engages in the pharmaceutical manufacturing industry in China. It offers injectable mouse nerve growth factor, human interferon, vaccines, traditional Chinese medicine decoction pieces, and pharmaceutical distribution. The company was founded in 1998 and is based in Shenzhen, China. Shandong Sinobioway Biomedicine Co., Ltd. is the subsidiary of Shenzhen Yilian Technology Co., Ltd. [Read more]

Sector Healthcare
Founded 1998
Employees 492
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002581
Full Company Profile

Financial Performance

In 2025, SHE:002581's revenue was 274.81 million, a decrease of -23.75% compared to the previous year's 360.41 million. Losses were -116.28 million, -15.32% less than in 2024.

Financial Statements